<DOC>
	<DOCNO>NCT00378417</DOCNO>
	<brief_summary>This randomize , double-blinded multicenter cohort study Finnish child age 2 24 month . The study design evaluate efficacy two 7-valent pneumococcal conjugate vaccine ( PncCRM PncOMPC ) parallelly , vaccine compare control vaccine ( hepatitis B vaccine ) . The primary endpoint culture-confirmed pneumococcal acute otitis medium ( AOM ) episode due serotypes include pneumococcal conjugate vaccine primary hypothesis , compare control vaccine group , pneumococcal conjugate vaccine would protect infant culture confirm AOM cause pneumococcal serotypes vaccine . The efficacy two vaccine pneumococcal AOM AOM also evaluate . The child vaccinate pneumococcal conjugate vaccine control vaccine age 2 , 4 , 6 12 month follow study clinic establish specifically purpose 2 24 month age . Whenever AOM diagnose follow-up , middle ear fluid aspirate bacterial culture .</brief_summary>
	<brief_title>Efficacy Trial Two Pneumococcal Conjugate Vaccines ( PncCRM PncOMPC ) Prevention Acute Otitis Media Due Vaccine Serotypes</brief_title>
	<detailed_description />
	<mesh_term>Otitis</mesh_term>
	<mesh_term>Otitis Media</mesh_term>
	<mesh_term>Pneumococcal Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>infant come child health center age 13 week , judge good health basis medical history physical examination family live permanently Tampere , Kangasala Nokia least one parents/guardians able communicate fluently Finnish write informed consent obtain parent/guardian prior enrollment study hypersensitivity component vaccine use study , know suspected impairment immunologic function , history invasive pneumococcal disease , prior vaccination pneumococcal vaccine , prior vaccination hepatitis B vaccine , contraindication routine childhood immunization medical condition , opinion investigator , study procedure vaccination might cause risk health endanger wellbeing child</criteria>
	<gender>All</gender>
	<minimum_age>6 Weeks</minimum_age>
	<maximum_age>12 Weeks</maximum_age>
	<verification_date>September 2006</verification_date>
	<keyword>Otitis Media</keyword>
	<keyword>Pneumococcal Infections</keyword>
	<keyword>Pneumococcal Vaccines</keyword>
	<keyword>Proportional Hazards Models</keyword>
	<keyword>Prospective Studies</keyword>
	<keyword>Streptococcus pneumoniae</keyword>
	<keyword>Vaccines , Conjugate</keyword>
</DOC>